On Wednesday, Boston Scientific experienced a loss of nearly one-fifth of its market capitalization in a single trading ...

Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance ...

Boston Scientific stock fell 8.4% despite beating Q4 earnings as weak Q1 guidance and electrophysiology division miss ...

Core Scientific provides blockchain infrastructure and digital asset mining for institutional and enterprise clients in North ...

Investors have seemingly homed in on flat sales in the Watchman and electrophysiology segments of Boston’s cardio portfolio, prompting a stock fall.

Boston Scientific stock took a beating Wednesday after sales of its most hyped segment missed expectations.

Boston Scientific Corporation (NYSE: BSX) reported Q4 2025 revenues of $5.29B, beating management guidance and consensus estimate.

View Boston Scientific Corporation BSX stock quote prices, financial information, real-time forecasts, and company news from CNN.